News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Brain Cancers Reveal Novel Genetic Disruption in DNA


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This needs to get into trials quickly.. however, caution (and a clinical trial) is needed because we do not know what else would be affected. For example, when the MGMT gene is methylated, the tumor is more sensitive to temodar and you live longer. Unmethylating it might put you into the worse prognosis group.



Website: http://mobile.nytimes.com/2015/12/24/health/brain-cancers-reveal-novel-genetic-disruption-in-dna.html?referer=

Posted on: 04/04/2016

Brain Cancers Reveal Novel Genetic Disruption in DNA

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740